Through multiple genomic profile studies, many genes have been sequenced in numerous tumor samples revealing the complex genetic profile of GBM, highlighting three signaling pathways commonly altered: the p53, tyrosine kinase receptor (RTK)/RAS/phosphoinositide 3-kinase (PI3K), and retinoblastoma (RB) pathways. Here, TP53 is linked to neoplasm.